Friday, July 10, 2026

biotech · Colorectal Liver Metastases

CSPC Pharmaceutical Group

CSPC Pharmaceutical Group clinical programs — 1 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

CN HQ
419 Employees
NMPA registrant Type
Company details
Status
Public
HQ
CN
Employees
419
Programs
1
Drugs
2
Patents
0
Intelligence · Clinical Programs

CSPC Pharmaceutical Group projects

1 ClinicalTrials.gov programs sponsored by CSPC Pharmaceutical Group.

CSPC Pharmaceutical Group has 1 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

Clinical programs

  1. paclitaxel cationic liposome for injection

    CSPC Baike (Shandong) Biopharmaceutical Co.,

    Colorectal Liver Metastases

    phase 1 small molecule active

    1 trial

Frequently asked questions

How many clinical projects does CSPC Pharmaceutical Group have?

1 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.